Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria

Title
Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-10
DOI
10.1038/s41467-020-16731-6

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now